Obstructive sleep apnea, immuno-inflammation, and atherosclerosis
- 29 April 2009
- journal article
- review article
- Published by Springer Nature in Seminars in Immunopathology
- Vol. 31 (1) , 113-125
Abstract
Obstructive sleep apnea (OSA) is a highly prevalent sleep disorder leading to cardiovascular and metabolic complications. OSA is also a multicomponent disorder, with intermittent hypoxia (IH) as the main trigger for the associated cardiovascular and metabolic alterations. Indeed, recurrent pharyngeal collapses during sleep lead to repetitive sequences of hypoxia–reoxygenation. This IH induces several consequences such as hemodynamic, hormonometabolic, oxidative, and immuno-inflammatory alterations that may interact and aggravate each other, resulting in artery changes, from adaptive to degenerative atherosclerotic remodeling. Atherosclerosis has been found in OSA patients free of other cardiovascular risk factors and is related to the severity of nocturnal hypoxia. Early stages of artery alteration, including functional and structural changes, have been evidenced in both OSA patients and rodents experimentally exposed to IH. Impaired vasoreactivity with endothelial dysfunction and/or increased vasoconstrictive responses due to sympathetic, endothelin, and renin–angiotensin systems have been reported and also contribute to vascular remodeling and inflammation. Oxidative stress, inflammation, and vascular remodeling can be directly triggered by IH, further aggravated by the OSA-associated hormonometabolic alterations, such as insulin resistance, dyslipidemia, and adipokine imbalance. As shown in OSA patients and in the animal model, genetic susceptibility, comorbidities (obesity), and life habits (high fat diet) may aggravate atherosclerosis development or progression. The intimate molecular mechanisms are still largely unknown, and their understanding may contribute to delineate new targets for prevention strategies and/or development of new treatment of OSA-related atherosclerosis, especially in patients at risk for cardiovascular disease.Keywords
This publication has 159 references indexed in Scilit:
- Dyslipidemia and Atherosclerosis Induced by Chronic Intermittent Hypoxia Are Attenuated by Deficiency of Stearoyl Coenzyme A DesaturaseCirculation Research, 2008
- Leptin ResistanceJACC, 2008
- Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytesPflügers Archiv - European Journal of Physiology, 2007
- Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetesThorax, 2007
- Inflammation and metabolic disordersNature, 2006
- Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulationThorax, 2006
- Chronic intermittent hypoxia activates nuclear factor-κB in cardiovascular tissues in vivoBiochemical and Biophysical Research Communications, 2006
- Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytesBiochemical and Biophysical Research Communications, 2006
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Inflammation in atherosclerosisNature, 2002